A review of one research paper.

Our review questions

Rising Use of Unapproved BPC-157 (“Wolverine Peptide”) and Associated Patient-Reported Outcomes Curated from Clinical Notes

Study review

In preparation

Not independently approved.

Paper published: 2026

Study at a glance

Design
Human clinical-note study · Preprint
Who or what was studied
Human

This unreviewed preprint identified 1,039 documented users, with response direction missing for 685.

Key limitation: Missing outcomes, co-treatments and an absent control group prevent a treatment-effect estimate.

Preview sources: PDF pages 9, 11

Review in preparation

This paper has a dedicated review record, but its full study appraisal is not yet available. It has not been counted as a completed review.

0 of 15 questions answered; 0 partly resolved; 15 awaiting assessment.

The original paper and references remain available above.